Functional chocolate brand Good Cacao and tomato-based heart-health ingredient Fruitflow took home this year’s NutrAward for best finished product and best new ingredient, respectively.
Functional chocolate brand Good Cacao and tomato-based heart-health ingredient Fruitflow took home this year’s NutrAward for best finished product and best new ingredient, respectively. The awards were presented at the Natural Products Expo West trade show in March.
Good Cacao calls itself the “world’s first organic superfood chocolate,” incorporating a range of high-profile brand-name functional ingredients. Ingredients range from Ganeden Biotech’s (Cleveland) Ganeden BC30 probiotics and Biothera’s (Eagan, MN) Wellmune WGP beta-glucan for immune health to Cognis’s (La Grange, IL) Heart Choice phytosterols, Martek Bioscience’s (Columbia, MD) life’sDHA, and Fuji Health Science’s (Burlington, NJ) AstaReal astaxanthin.
Cardio-health ingredient Fruitflow is a water-soluble, tomato-based ingredient originally developed by UK-based firm Provexis and marketed in partnership with DSM Nutritional Products (Parsippany, NJ) since last year. By supporting healthy platelet aggregation-through mechanisms such as smoothing blood platelets and preventing unnatural clumping-the ingredient helps stimulate blood flow and support overall cardiovascular health. The ingredient was the first-and is now only one of two-ingredients approved for a health claim by the European Food Safety Authority. (The other is CreaNutrition’s oat beta-glucan, which now merits a claim for supporting healthy cholesterol.)
In a press release, DSM’s senior marketing manager Reto Rieder says that that seven human studies, two published, have been done on Fruitflow. He adds that in the cardiovascular-health category, in which ingredients largely target cholesterol management, there aren’t a lot of contending ingredients for maintaining healthy circulation.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.